微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.82% | 51.85% | 645.45% | 91/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 0.11% | 104.62% | -90% | 99/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 1.1% | 168.29% | 5.77% | 99/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 1.04% | -2.8% | 92.59% | 93/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 0.54% | -22.86% | 122.69% | 97/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | -2.38% | -216.67% | -680.49% | 108/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 0.41% | -81.61% | -61.68% | 107/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 1.07% | -28.19% | 52.86% | 101/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 0.7% | 29.63% | -65.69% | 100/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 2.04% | 141.46% | -8.52% | 88/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 2.23% | 134.74% | 49.66% | 103/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 1.49% | -36.86% | 175.93% | 93/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 0.54% | -85.08% | 110.98% | 106/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -4.92% | -132.26% | -617.89% | 117/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 0.95% | -91.44% | -59.75% | 106/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 2.36% | -71.84% | -34.81% | 77/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 3.62% | 4.32% | -76.26% | 23/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 15.25% | -13.2% | 37.39% | 19/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 11.1% | -32.36% | 32.46% | 26/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 8.38% | -35.74% | 141.5% | 21/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 3.47% | -22.54% | -80.25% | 31/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 17.57% | -1.35% | 7.07% | 27/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 16.41% | 12.4% | 25.84% | 12/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 13.04% | 33.06% | 191.07% | 9/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 4.48% | -8.01% | -74.85% | 16/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 17.81% | 62.65% | 21.99% | 23/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 14.6% | 55.98% | 48.98% | 13/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 9.8% | 37.06% | 101.23% | 15/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 4.87% | 90.98% | -55.53% | 12/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 10.95% | 52.51% | 16.99% | 46/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 9.36% | 10.64% | 30.91% | 27/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 7.15% | 14.95% | 180.39% | 22/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 2.55% | -25% | -64.48% | 40/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 7.18% | -30.29% | -15.13% | 71/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 8.46% | -8.24% | 36.01% | 37/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 6.22% | -17.07% | 82.94% | 32/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 3.4% | -38.85% | -66.99% | 20/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 10.3% | -35.42% | 11.71% | 54/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 9.22% | -21.73% | 22.93% | 28/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 7.5% | 2% | 34.89% | 25/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 5.56% | 2% | -65.14% | 10/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |